- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens purchase of Acuson cleared in Germany
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound vendor, at $23 a share.
The offer, which would merge the American firm into a wholly owned subsidiary of Siemens and create the world's largest ultrasound company, remains conditional on expiration of the waiting period under U.S. antitrust law.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
